Literature DB >> 23053058

Search for schizophrenia susceptibility variants at the HLA-DRB1 locus among a British population.

Lorna Halley1, Mary K Doherty, Ian L Megson, Neil McNamara, Andy Gadja, Jun Wei.   

Abstract

Schizophrenia is a complex mental disorder with unknown aetiology. Both candidate gene and genome-wide association (GWA) studies suggest that the human leukocyte antigen (HLA) system may play a part in development of the illness, but the causal HLA variant(s) remain(s) unclear. Previous studies showed that the DRB1*0101 and DRB1*13 alleles might be associated with a high risk of schizophrenia. Therefore, the present study was undertaken to test their association with the disease by genotyping seven DRB1-tagging single nucleotide polymorphisms (SNPs) in a British population. The results showed that, of the previously reported variants that were associated with schizophrenia, the DRB1*1303 allele was the only one marginally associated with a protective effect on the illness in our sample set (χ² = 4.138, P = 0.042, odds ratio (OR) = 0.42, 95 % confidence interval (CI) 0.27-0.66). Interestingly, a significant association was found for rs424232 (χ² = 9.404, P = 0.002, OR = 0.69, 95 % CI 0.54-0.88), which is a tag SNP for the DRB1*1303 allele and located near to the NOTCH4 gene that is a schizophrenia susceptibility locus confirmed by GWA studies. Analysis with the Haploview program demonstrated that rs424232 was in complete linkage disequilibrium with rs3130297 and rs3131296 present in the NOTCH4 locus. While we have failed to confirm association of the candidate alleles in the DRB1 gene with a high risk of schizophrenia, the present work suggests that the association signal detected in the HLA class II locus may extend a relatively long distance, and more work is needed in order to identify the true causal variants within this region or nearby.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053058     DOI: 10.1007/s00251-012-0652-y

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  31 in total

1.  Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Crystal Vaughan; Sunil Khushalani; Flora Leister; Shuojia Yang; Bogdana Krivogorsky; Armin Alaedini; Robert Yolken
Journal:  Biol Psychiatry       Date:  2010-05-14       Impact factor: 13.382

2.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.

Authors:  Johann Steiner; Hendrik Bielau; Ralf Brisch; Peter Danos; Oliver Ullrich; Christian Mawrin; Hans-Gert Bernstein; Bernhard Bogerts
Journal:  J Psychiatr Res       Date:  2006-12-15       Impact factor: 4.791

3.  Comparison of RFLP-DR beta and serological HLA-DR typing in 1500 individuals.

Authors:  J Mytilineos; S Scherer; G Opelz
Journal:  Transplantation       Date:  1990-11       Impact factor: 4.939

4.  A study of circulating gliadin antibodies in schizophrenia among a Chinese population.

Authors:  Shun-Zi Jin; Ning Wu; Qi Xu; Xuan Zhang; Gui-Zhi Ju; Matthew H Law; Jun Wei
Journal:  Schizophr Bull       Date:  2010-09-30       Impact factor: 9.306

5.  Dietary antigens, epitope recognition, and immune complex formation in recent onset psychosis and long-term schizophrenia.

Authors:  Emily G Severance; Jing Lin; Hugh A Sampson; Gustavo Gimenez; Faith B Dickerson; Meredith Halling; Kristin Gressitt; Luladey Haile; Cassie R Stallings; Andrea E Origoni; Didier Dupont; Robert H Yolken
Journal:  Schizophr Res       Date:  2011-01-06       Impact factor: 4.939

6.  Transmission disequilibrium analysis of HLA class II DRB1, DQA1, DQB1 and DPB1 polymorphisms in schizophrenia using family trios from a Han Chinese population.

Authors:  T Li; J Underhill; X H Liu; P C Sham; P Donaldson; R M Murray; P Wright; D A Collier
Journal:  Schizophr Res       Date:  2001-04-15       Impact factor: 4.939

7.  Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data.

Authors:  Frank Dudbridge
Journal:  Hum Hered       Date:  2008-03-31       Impact factor: 0.444

8.  Common variants on chromosome 6p22.1 are associated with schizophrenia.

Authors:  Jianxin Shi; Douglas F Levinson; Jubao Duan; Alan R Sanders; Yonglan Zheng; Itsik Pe'er; Frank Dudbridge; Peter A Holmans; Alice S Whittemore; Bryan J Mowry; Ann Olincy; Farooq Amin; C Robert Cloninger; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Raymond R Crowe; Jorge R Oksenberg; Daniel B Mirel; Kenneth S Kendler; Robert Freedman; Pablo V Gejman
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

Review 9.  Schizophrenia and HLA: a review.

Authors:  P Wright; V L Nimgaonkar; P T Donaldson; R M Murray
Journal:  Schizophr Res       Date:  2001-01-15       Impact factor: 4.939

10.  Novel immune response to gluten in individuals with schizophrenia.

Authors:  Diana Samaroo; Faith Dickerson; Donald D Kasarda; Peter H R Green; Chiara Briani; Robert H Yolken; Armin Alaedini
Journal:  Schizophr Res       Date:  2009-09-11       Impact factor: 4.939

View more
  3 in total

1.  Association of HLA-DQA1 (rs9272219) with susceptibility to rheumatoid arthritis in a Han Chinese population.

Authors:  Gui-Feng Hao; Ya-Song Li; Jin-Lin Liu; Ming-Yi Wo
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  Association of HLA-DR/DQ polymorphisms with schizophrenia in Tunisian patients.

Authors:  Aicha Sayeh; Cheker Ben Cheikh; Meriem Mrad; Najwa Lakhal; Nasreddine Gritli; Slaheddine Galelli; Abdelaziz Oumaya; Najiba Fekih-Mrissa
Journal:  Ann Saudi Med       Date:  2014 Nov-Dec       Impact factor: 1.526

3.  Association of the NOTCH4 Gene Polymorphism rs204993 with Schizophrenia in the Chinese Han Population.

Authors:  Bao Zhang; Qian Rui Fan; Wen Hao Li; Ning Lu; Dong Ke Fu; Yan Jie Kang; Na Wang; Teng Li; Xiao Peng Wen; Da Xu Li
Journal:  Biomed Res Int       Date:  2015-10-28       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.